300 related articles for article (PubMed ID: 12198334)
1. N(G)-nitro-L-arginine methyl ester-induced hypertension and natriuretic peptide gene expression: inhibition by angiotensin II type 1 receptor antagonism.
Suo M; Kalliovalkama J; Pörsti I; Jolma P; Tolvanen JP; Vuolteenaho O; Ruskoaho H
J Cardiovasc Pharmacol; 2002 Sep; 40(3):478-86. PubMed ID: 12198334
[TBL] [Abstract][Full Text] [Related]
2. Differential regulation of cardiac adrenomedullin and natriuretic peptide gene expression by AT1 receptor antagonism and ACE inhibition in normotensive and hypertensive rats.
Magga J; Kalliovalkama J; Romppanen H; Vuolteenaho O; Pörsti I; Kähönen M; Tolvanen JP; Ruskoaho H
J Hypertens; 1999 Nov; 17(11):1543-52. PubMed ID: 10608466
[TBL] [Abstract][Full Text] [Related]
3. Arterial function in nitric oxide-deficient hypertension: influence of long-term angiotensin II receptor antagonism.
Kalliovalkama J; Jolma P; Tolvanen JP; Kähönen M; Hutri-Kähönen N; Wu X; Holm P; Pörsti I
Cardiovasc Res; 1999 Jun; 42(3):773-82. PubMed ID: 10533618
[TBL] [Abstract][Full Text] [Related]
4. Role of nitric oxide on cardiac hormone secretion: effect of NG-nitro-L-arginine methyl ester on atrial natriuretic peptide and brain natriuretic peptide release.
Leskinen H; Vuolteenaho O; Leppäluoto J; Ruskoaho H
Endocrinology; 1995 Mar; 136(3):1241-9. PubMed ID: 7867578
[TBL] [Abstract][Full Text] [Related]
5. Angiotensin II type 1 receptor antagonism improves endothelial vasodilator function in L-NAME-induced hypertensive rats by a kinin-dependent mechanism.
De Gennaro Colonna V; Fioretti S; Rigamonti A; Bonomo S; Manfredi B; Muller EE; Berti F; Rossoni G
J Hypertens; 2006 Jan; 24(1):95-102. PubMed ID: 16331106
[TBL] [Abstract][Full Text] [Related]
6. Discoordinate re-expression of cardiac fetal genes in N(omega)-nitro-L-arginine methyl ester (L-NAME) hypertension.
Zhang Y; Carreras D; de Bold AJ
Cardiovasc Res; 2003 Jan; 57(1):158-67. PubMed ID: 12504825
[TBL] [Abstract][Full Text] [Related]
7. Angiotensin-converting enzyme inhibition and angiotensin AT1-receptor antagonism equally improve endothelial vasodilator function in L-NAME-induced hypertensive rats.
De Gennaro Colonna V; Rigamonti A; Fioretti S; Bonomo S; Manfredi B; Ferrario P; Bianchi M; Berti F; Muller EE; Rossoni G
Eur J Pharmacol; 2005 Jun; 516(3):253-9. PubMed ID: 15963975
[TBL] [Abstract][Full Text] [Related]
8. Angiotensin II subtype AT1 receptor blockade prevents hypertension and renal insufficiency induced by chronic NO-synthase inhibition in rats.
Hropot M; Langer KH; Wiemer G; Grötsch H; Linz W
Naunyn Schmiedebergs Arch Pharmacol; 2003 Mar; 367(3):312-7. PubMed ID: 12644905
[TBL] [Abstract][Full Text] [Related]
9. Role of NO and angiotensin II in the early development of endothelial functions impairment and cardiac hypertrophy in deoxycorticosterone acetate-salt hypertension.
K-Laflamme A; Oster L; Cardinal R; de Champlain J
Can J Physiol Pharmacol; 1998 Jun; 76(6):665-75. PubMed ID: 9923405
[TBL] [Abstract][Full Text] [Related]
10. Hepatic morphological alterations, glycogen content and cytochrome P450 activities in rats treated chronically with N(omega)-nitro-L-arginine methyl ester (L-NAME).
Tarsitano CA; Paffaro VA; Pauli JR; da Silva GH; Saad MJ; Salgado I; da Cruz-Höfling MA; Hyslop S
Cell Tissue Res; 2007 Jul; 329(1):45-58. PubMed ID: 17436021
[TBL] [Abstract][Full Text] [Related]
11. Sympathetic functions in NG-nitro-L-arginine-methyl-ester-induced hypertension: modulation by the renin-angiotensin system.
K-Laflamme A; Foucart S; Moreau P; Lambert C; Cardinal R; de Champlain J
J Hypertens; 1998 Jan; 16(1):63-76. PubMed ID: 9533419
[TBL] [Abstract][Full Text] [Related]
12. Differential subcellular actions of ACE inhibitors and AT(1) receptor antagonists on cardiac remodeling induced by chronic inhibition of NO synthesis in rats.
Sanada S; Kitakaze M; Node K; Takashima S; Ogai A; Asanuma H; Sakata Y; Asakura M; Ogita H; Liao Y; Fukushima T; Yamada J; Minamino T; Kuzuya T; Hori M
Hypertension; 2001 Sep; 38(3):404-11. PubMed ID: 11566913
[TBL] [Abstract][Full Text] [Related]
13. Angiotensin II type 1 receptor blocker prevents atrial structural remodeling in rats with hypertension induced by chronic nitric oxide inhibition.
Okazaki H; Minamino T; Tsukamoto O; Kim J; Okada K; Myoishi M; Wakeno M; Takashima S; Mochizuki N; Kitakaze M
Hypertens Res; 2006 Apr; 29(4):277-84. PubMed ID: 16778335
[TBL] [Abstract][Full Text] [Related]
14. Prostacyclin and thromboxane A2 production in nitric oxide-deficient hypertension in vivo. Effects of high calcium diet and angiotensin receptor blockade.
Alanko J; Jolma P; Kööbi P; Riutta A; Kalliovalkama J; Tolvanen JP; Pörsti I
Prostaglandins Leukot Essent Fatty Acids; 2003 Nov; 69(5):345-50. PubMed ID: 14580369
[TBL] [Abstract][Full Text] [Related]
15. Role of Angiotensin II type 1 receptor on renal NAD(P)H oxidase, oxidative stress and inflammation in nitric oxide inhibition induced-hypertension.
Rincón J; Correia D; Arcaya JL; Finol E; Fernández A; Pérez M; Yaguas K; Talavera E; Chávez M; Summer R; Romero F
Life Sci; 2015 Mar; 124():81-90. PubMed ID: 25623850
[TBL] [Abstract][Full Text] [Related]
16. Renal and vascular effects of chronic nitric oxide synthase inhibition: involvement of endothelin 1 and angiotensin II.
D'Amours M; Lebel M; Grose JH; Larivière R
Can J Physiol Pharmacol; 1999 Jan; 77(1):8-16. PubMed ID: 10535660
[TBL] [Abstract][Full Text] [Related]
17. Effects of bradykinin on cardiovascular remodeling in renovascular hypertensive rats.
Tanaka Y; Nagai M; Date T; Okada T; Abe Y; Seki S; Taniguchi M; Taniguchi I; Mochizuki S
Hypertens Res; 2004 Nov; 27(11):865-75. PubMed ID: 15824469
[TBL] [Abstract][Full Text] [Related]
18. Angiotensin II activates collagen type I gene in the renal vasculature of transgenic mice during inhibition of nitric oxide synthesis: evidence for an endothelin-mediated mechanism.
Boffa JJ; Tharaux PL; Placier S; Ardaillou R; Dussaule JC; Chatziantoniou C
Circulation; 1999 Nov; 100(18):1901-8. PubMed ID: 10545435
[TBL] [Abstract][Full Text] [Related]
19. Comparison of effect of endothelin antagonism and angiotensin-converting enzyme inhibition on blood pressure and vascular structure in spontaneously hypertensive rats treated with N omega-nitro-L-arginine methyl ester. Correlation with topography of vascular endothelin-1 gene expression.
Li JS; Deng LY; Grove K; Deschepper CF; Schiffrin EL
Hypertension; 1996 Aug; 28(2):188-95. PubMed ID: 8707380
[TBL] [Abstract][Full Text] [Related]
20. [Contribution of the renin-angiotensin system to the variability of blood pressure in hypertensive rat after blockade of nitric oxide synthesis].
Gouédard O; Gaudet E; Blanc J; Ponchon P; Elghozi JL
Arch Mal Coeur Vaiss; 1996 Aug; 89(8):1013-7. PubMed ID: 8949370
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]